PFE Pfizer Inc

Price (delayed)

$26.26

Market cap

$148.28B

P/E Ratio

69.11

Dividend/share

$1.65

EPS

$0.38

Enterprise value

$217.32B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights
The price to earnings (P/E) is 149% higher than the last 4 quarters average of 27.8
PFE's debt has soared by 101% YoY and by 13% from the previous quarter

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.65B
Market cap
$148.28B
Enterprise value
$217.32B
Valuations
Price to book (P/B)
1.67
Price to sales (P/S)
2.53
EV/EBIT
216.45
EV/EBITDA
29.79
EV/Sales
3.72
Earnings
Revenue
$58.5B
EBIT
$1B
EBITDA
$7.29B
Free cash flow
$4.79B
Per share
EPS
$0.38
Free cash flow per share
$0.85
Book value per share
$15.76
Revenue per share
$10.37
TBVPS
$16.63
Balance sheet
Total assets
$226.5B
Total liabilities
$137.21B
Debt
$71.89B
Equity
$89.01B
Working capital
-$4.46B
Liquidity
Debt to equity
0.81
Current ratio
0.91
Quick ratio
0.5
Net debt/EBITDA
9.46
Margins
EBITDA margin
12.5%
Gross margin
57.3%
Net margin
3.6%
Operating margin
1.8%
Efficiency
Return on assets
1%
Return on equity
2.2%
Return on invested capital
0.8%
Return on capital employed
0.6%
Return on sales
1.7%
Dividend
Dividend yield
6.28%
DPS
$1.65
Payout ratio
434.2%

PFE stock price

How has the Pfizer stock price performed over time
Intraday
1%
1 week
1.35%
1 month
-4.02%
1 year
-34.69%
YTD
-8.79%
QTD
-5.37%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$58.5B
Gross profit
$33.54B
Operating income
$1.06B
Net income
$2.12B
Gross margin
57.3%
Net margin
3.6%
The operating income has plunged by 97% YoY and by 90% from the previous quarter
The company's operating margin has shrunk by 95% YoY and by 88% QoQ
Pfizer's net income has shrunk by 93% YoY and by 80% QoQ
PFE's net margin has plunged by 88% YoY and by 76% from the previous quarter

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
P/E
69.11
P/B
1.67
P/S
2.53
EV/EBIT
216.45
EV/EBITDA
29.79
EV/Sales
3.72
The price to earnings (P/E) is 149% higher than the last 4 quarters average of 27.8
Pfizer's EPS has plunged by 93% YoY and by 79% from the previous quarter
PFE's P/B is 44% below its 5-year quarterly average of 3.0 and 17% below its last 4 quarters average of 2.0
Pfizer's equity has decreased by 8% QoQ and by 7% YoY
Pfizer's revenue has decreased by 42% YoY and by 15% QoQ
PFE's P/S is 37% below its 5-year quarterly average of 4.0 and 6% below its last 4 quarters average of 2.7

Efficiency

How efficient is Pfizer business performance
The company's return on invested capital has shrunk by 98% YoY and by 90% QoQ
Pfizer's ROS has plunged by 95% YoY and by 89% from the previous quarter
The ROE has shrunk by 94% YoY and by 79% QoQ
Pfizer's ROA has plunged by 94% YoY and by 80% from the previous quarter

Dividends

What is PFE's dividend history
DPS
$1.65
Dividend yield
6.28%
Payout ratio
434.2%
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 65% greater than its total liabilities
The quick ratio has plunged by 72% from the previous quarter and by 38% YoY
The current ratio has plunged by 62% from the previous quarter and by 25% YoY
PFE's debt is 19% less than its equity
The debt to equity has soared by 119% YoY and by 23% from the previous quarter
PFE's debt has soared by 101% YoY and by 13% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.